Literature DB >> 34350480

Screening for anxiety disorders in third trimester pregnancy: a comparison of four brief measures.

Marie-Paule V Austin1,2,3, Victoria Mule4,5, Dusan Hadzi-Pavlovic5, Nicole Reilly4,5,6.   

Abstract

Evidence regarding the accuracy of existing anxiety screeners used in pregnancy is limited. This study compares the psychometric characteristics of the Generalized Anxiety Disorder 2- and 7-item Scales (GAD-2 and GAD-7), the anxiety subscale of the Edinburgh Postnatal Depression Scale (EPDS-3A) and the two anxiety items of the Antenatal Risk Questionnaire (ANRQ-2A). Nine hundred fifty-four women completed the screening measures and anxiety modules of a diagnostic reference standard (SAGE-SR) in the third trimester. Test performance characteristics of each measure was assessed using Receiver Operator Characteristic (ROC) analysis. We applied four previously recommended criteria to ascertain the value of each measure for widespread clinical use: area under the curve (AUC ≥ 0.8, Youden's index ≥ 0.5, negative predictive value (NPV) ≥ 0.8 and positive likelihood ratio (LR +) ≥ 4.0). Prevalence for any SAGE-SR anxiety disorder was 3%. All measures yielded an acceptable AUC of ≥ 0.8, Youden's index of ≥ 0.5 and NPV of ≥ 0.8. Only the EPDS-3A, at a cut-point ≥ 5, also achieved a LR + of ≥ 4.0 (4.35) but at this cut-point sensitivity was less than 0.75. The ANRQ-2A, at its optimal cut-point of ≥ 6, was the only measure to additionally attain both a sensitivity and specificity of ≥ .75. This study expands the evidence base for brief anxiety screening measures in the maternity setting and provides empirical support for the use of the EPDS-3A and ANRQ-2A in routine screening programmes. Studies assessing the performance of these measures in samples with higher disease prevalence and broader socio-economic status are warranted.
© 2021. Crown.

Entities:  

Keywords:  Perinatal anxiety; Screening; Test accuracy; Validation

Mesh:

Year:  2021        PMID: 34350480     DOI: 10.1007/s00737-021-01166-9

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  10 in total

1.  Agreement between clinical and MINI diagnoses in outpatients with mood and anxiety disorders.

Authors:  F E A Verhoeven; L S M A Swaab; I V E Carlier; A M van Hemert; F G Zitman; H G Ruhé; R A Schoevers; E J Giltay
Journal:  J Affect Disord       Date:  2017-06-22       Impact factor: 4.839

2.  A randomized controlled trial of 'MUMentum Pregnancy': Internet-delivered cognitive behavioral therapy program for antenatal anxiety and depression.

Authors:  Siobhan A Loughnan; Amanda Sie; Megan J Hobbs; Amy E Joubert; Jessica Smith; Hila Haskelberg; Alison E J Mahoney; Natalie Kladnitski; Christopher J Holt; Jeannette Milgrom; Marie-Paule Austin; Gavin Andrews; Jill M Newby
Journal:  J Affect Disord       Date:  2018-09-21       Impact factor: 4.839

3.  The antenatal risk questionnaire (ANRQ): acceptability and use for psychosocial risk assessment in the maternity setting.

Authors:  Marie-Paule Austin; Jana Colton; Susan Priest; Nicole Reilly; Dusan Hadzi-Pavlovic
Journal:  Women Birth       Date:  2011-07-20       Impact factor: 3.172

Review 4.  Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis.

Authors:  Cindy-Lee Dennis; Kobra Falah-Hassani; Rahman Shiri
Journal:  Br J Psychiatry       Date:  2017-03-16       Impact factor: 9.319

Review 5.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

6.  Short screening scales to monitor population prevalences and trends in non-specific psychological distress.

Authors:  R C Kessler; G Andrews; L J Colpe; E Hiripi; D K Mroczek; S L T Normand; E E Walters; A M Zaslavsky
Journal:  Psychol Med       Date:  2002-08       Impact factor: 7.723

7.  The Perinatal Anxiety Screening Scale: development and preliminary validation.

Authors:  Susanne Somerville; Kellie Dedman; Rosemary Hagan; Elizabeth Oxnam; Michelle Wettinger; Shannon Byrne; Soledad Coo; Dorota Doherty; Andrew C Page
Journal:  Arch Womens Ment Health       Date:  2014-04-04       Impact factor: 3.633

8.  Comparative efficacy of the generalized anxiety disorder 7-item scale and the Edinburgh Postnatal Depression Scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum period.

Authors:  William Simpson; Melanie Glazer; Natalie Michalski; Meir Steiner; Benicio N Frey
Journal:  Can J Psychiatry       Date:  2014-08       Impact factor: 4.356

9.  Study protocol for a comparative effectiveness trial of two models of perinatal integrated psychosocial assessment: the PIPA project.

Authors:  Nicole Reilly; Emma Black; Georgina M Chambers; Virginia Schmied; Stephen Matthey; Josephine Farrell; Dawn Kingston; Andrew Bisits; Marie-Paule Austin
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-20       Impact factor: 3.007

10.  Prevalence and identification of anxiety disorders in pregnancy: the diagnostic accuracy of the two-item Generalised Anxiety Disorder scale (GAD-2).

Authors:  Selina Nath; Elizabeth G Ryan; Kylee Trevillion; Debra Bick; Jill Demilew; Jeannette Milgrom; Andrew Pickles; Louise M Howard
Journal:  BMJ Open       Date:  2018-09-05       Impact factor: 2.692

  10 in total
  1 in total

1.  Pregnant Women's Anxiety and Depression Symptoms and Influence Factors in the COVID-19 Pandemic in Changzhou, China.

Authors:  Li Wang; Ni Yang; Hua Zhou; Xueqin Mao; Ying Zhou
Journal:  Front Psychol       Date:  2022-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.